Publication | Open Access
Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration
491
Citations
39
References
2019
Year
Local C3 inhibition with pegcetacoplan resulted in statistically significant reductions in the growth of GA compared with sham treatment. Phase 3 studies will define the efficacy and safety profile further.
| Year | Citations | |
|---|---|---|
Page 1
Page 1